Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 592 shares at $141.38 ($84K) on 2016-02-05, disclosed to the SEC on 2016-02-08.
Seasonal sale ($84k) by Director — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |